Skip to main content
 

2026 South Carolina HIV, STD and Viral Hepatitis Conference: Against All Odds: Shaping Resilient Communities


South Carolina HIV, STD and Viral Hepatitis Conference
October 21 & 22, 2026
Columbia Metropolitan Convention Center
1101 Lincoln Street
Columbia, South Carolina 29201
 
Conference information, please visit www.schiv-stdconference.org.
To register for the conference via mail, please follow the instructions on the conference website (or in Conference flyer below).
 
 
 
 
Registration Fees:
TIMELINE
SINGLE DAY REGISTRATION
+ ACPE CREDIT
= Price
FULL CONFERENCE (BOTH DAYS)
+ ACPE CREDIT
= Price
Late Registration
Deadline: after October 9
 $220C
+ $15 
= $235C
 $425C
+ $15 
= $440C
On-site Registration
Deadline: after October 9
$270C
+ $15 
= $285C
$525C
+ $15 
= $540C
Student Registration*
Deadline: September 10
$65*C
N/A
$130*C
N/A
*Students will be required to submit a scanned copy of their school ID (with photo) along with their registration, and MUST present their ID at registration table on-site.
COnline convenience fee (if paying onling)
 
Important Information:
- As noted in columns 3 & 5, if you are pursuing ACPE Pharmacy credit, there is an additional $15.
- Please view the registration website and Conference (PDF) Flyer for more information. 
 
The SC HIV, STD and Viral Hepatitis Conference is designed for nurse practitioners, physician assistants, nurses, other clinicians, HIV/STD/Viral Hepatitis educators, social workers, case managers, public health professionals, pharmacists, other service providers, teachers, students, people living with HIV/AIDS and other interested community members. The mission for this interdisciplinary conference is to provide opportunities for professionals and community members to engage in dialogue and share past successes, discuss current practices and interventions, as well as address emerging issues and trends.
 
A total of 6 of the concurrent sessions are ACPE-accredited for pharmacists, and pharmacists may claim a maximum of 6.0 live contact hours (0.6 CEUs) of application and knowledge-based continuing pharmacy education.  Please select the plus sign "+" next to the session(s) below to view additional details for the session. The ACPE (PDF) Activity Announcement also contains the information below!
 

Date: Oct 21, 2026 08:00 AM - Oct 22, 2026 03:00 PM

Fee

$0.00

CE Hours

6.00

CE Units

0.600

Activity Type

Knowledge-Based and Application-Based

Target Audience(s)

Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education with Commendation
University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

Requirements for CE Credit

Participants must sign in upon arrival and have attendance verified. 
 
To claim credit for this activity, participants must complete the online program evaluation and must update their accounts to properly reflect their month/day of birth and correct NABP e-Profile ID.  To register with NABP or look up your NABP e-Profile ID, please click on the CPE Monitor logo below to be directed to their site. 
 
Credit that is claimed greater than 60 days from the date of the program will be automatically rejected by the CPE Monitor.  Claiming credit within 30 days of the live program will ensure that any issues with transmission to the CPE Monitor can be rectified in advance of the 60-day deadline.  If you would like a paper statement of credit, you may print an individual statement or a transcript from your NABP e-Profile.
 
 
 

2026 South Carolina HIV, STD and Viral Hepatitis Conference: Against All Odds: Shaping Resilient Communities
 

Wed, Oct 21, 2026
 

Implementation Science of Long-Acting Injectable Antiretroviral Therapy
 

At the completion of this activity, the participant will be able to:
  1. Describe the current landscape of long-acting injectable agents for HIV treatment and prevention
  2. Evaluate the implementation science behind incorporating LAI agents into clinical practice
  3. Discuss the future of LAI agents for HIV treatment and prevention
 

Speaker(s)/Author(s)

Caroline Derrick, PharmD, BCPS, AAHIVP
Infectious Diseases Ambulatory Pharmacy Supervisor, USC School of Medicine, Department of Internal Medicine, Prisma Health-Midlands

Activity Number

0062-9999-26-110-L02-P
Date: 10/21/26
Time: 10:45 AM - 11:45 AM

CE Hours

1.00
 

"Gas Station Drugs": Emerging Trends with Drugs of Abuse
 

At the completion of this activity, the participant will be able to:
  1. Identify commonly encountered “gas station drugs” by their street names and active ingredients
  2. Describe the pharmacology, clinical effects, and toxicity of these substances, with emphasis on opioid-like activity and co-use
  3. Discuss clinical considerations, including detection challenges, patient counseling, and harm reduction strategies for patients using “gas station drugs”

Speaker(s)/Author(s)

Lauren Linder Wier, PharmD, BCPP
Clinical Assistant Professor, USC College of Pharmacy

Activity Number

0062-9999-26-111-L01-P
Date: 10/21/26
Time: 11:55 AM - 12:55 PM

CE Hours

1.00
 

Barriers and Facilitators to Hepatitis B Vaccination in Rural Community Pharmacies
 

At the completion of this activity, the participant will be able to:
  1. Identify key barriers and facilitators to hepatitis B vaccination in rural community pharmacies serving persons living with HIV
  2. Describe financial, structural, and workflow factors that impact implementation of hepatitis B vaccination in rural community pharmacy settings
  3. Discuss potential strategies to improve hepatitis B vaccination uptake among people living with HIV in rural community pharmacies

Speaker(s)/Author(s)

Macie Goodman, PharmD, PhD Candidate
USC College of Pharmacy

Activity Number

0062-9999-26-112-L06-P
Date: 10/21/26
Time: 02:50 PM - 03:50 PM

CE Hours

1.00
 

Getting a grip on PIP: Examining HIV Post-Exposure Prophylaxis in Pocket (PIP)
 

At the completion of this activity, the participant will be able to:
  1. Compare Post-Exposure Prophylaxis in Pocket (PIP) to other forms of HIV prevention
  2. Discuss the benefits and challenges of using PIP from consumers’ perspectives
  3. Examine clinicians’ views on prescribing and monitoring PIP for use on a situational basis

Speaker(s)/Author(s)

Kenric Ware, PharmD, MBA, AAHIVP
Clinical Associate Professor, Mercer University College of Pharmacy

Activity Number

0062-9999-26-113-L02-P
Date: 10/21/26
Time: 04:00 PM - 05:00 PM

CE Hours

1.00
 

Thu, Oct 22, 2026
 

Approved and Investigational HIV Treatment Options
 

At the completion of this activity, the participant will be able to:
  1. Identify the basic principles of the HIV viral life cycle
  2. Describe currently approved medications to treat HIV infection work
  3. Review investigational medications and approaches being evaluated for HIV treatment and cure

Speaker(s)/Author(s)

Eric Meissner, MD, PhD
Associate Professor of Medicine, Director of HIV and Hepatitis Patient Care and Research, Medical University of South Carolina (MUSC)

Activity Number

0062-9999-26-114-L02-P
Date: 10/22/26
Time: 10:45 AM - 11:45 AM

CE Hours

1.00
 

Challenging and Interesting Syphilis Cases
 

At the completion of this activity, the participant will be able to:
  1. Describe current epidemiologic trends and populations disproportionately affected by syphilis in the United States
  2. Apply evidence-based syphilis prevention, diagnostic, treatment, and follow-up recommendations to clinical case scenarios
  3. Develop an action plan to enhance syphilis prevention, diagnosis, or management within your practice

Speaker(s)/Author(s)

Jennifer L. Nall, MMS, MPH, PA-C
Physician Assistant, Department of Internal Medicine, Section on Infectious Diseases, Atrium Health Wake Forest Baptist

Activity Number

0062-9999-26-131-L01-P
Date: 10/22/26
Time: 11:55 AM - 12:55 PM

CE Hours

1.00